共 49 条
[1]
Avedisova A.S., Verigo N.N., Cognitive deficit in schizophrenia, Ros. Psikhiat. Zh., 3, pp. 21-24, (2002)
[2]
Alfimova M.V., Trubnikov V.I., Inter-individual differences in the characteristics of cognitive activity in patients with and subjects at high risk of schizophrenia, Sots. Klin. Psikhiat., 9, 2, pp. 5-13, (1999)
[3]
Golimbet V.E., Alfimova M.V., Mityushina N.F., Et al., Association of the T102C locus of the 5HTR2A gene with attention and memory functions in patients with schizophrenia, Med. Genet., 3, 7, pp. 340-344, (2004)
[4]
Kabanov S.O., Mosolov S.N., Neuroleptics and neurocognitive deficit in schizophrenia, Ros. Psikhiat. Zh., 5, pp. 60-68, (2003)
[5]
Kritskaya V.P., Meleshko T.K., Polyakov Yu.F., Pathology of Mental Activity in Schizophrenia: Motivation, Association, and Knowledge, (1991)
[6]
Magomedova M.V., Neurocognitive deficit and its relationship with the level of social competence in patients with schizophrenia, Sots. Klin. Psikhiat., 1, pp. 92-98, (2000)
[7]
Mosolov S.N., Scales for the Psychometric Assessment of the Symptoms of Schizophrenia and the Concepts of Positive and Negative Disturbances, (2001)
[8]
Molosov S.N., Kabanov S.O., Effects of prolonged treatment with quetiapine in patients with paranoid schizophrenia, Zh. Nevrol. Psikhiat., 104, 6, pp. 27-34, (2004)
[9]
Akil M., Kolachana B.S., Rothmond D.A., Et al., Catechol-O-methyl-transferase genotype and dopamine regulation in the human brain, J. Neurosci., 23, pp. 2008-2013, (2003)
[10]
Bearden C.E., Jawad A.F., Lynch D.R., Et al., Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22qll.2 deletion syndrome, Amer. J. Psychiat., 161, pp. 1700-1702, (2004)